Results 41 to 50 of about 190,206 (302)
The Journal of Clinical Endocrinology & Metabolism, 2007 Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu Garg, Vinaya Simha
openaire +3 more sources
Clinical Cardiology, Volume 45, Issue 12, Page 1264-1271, December 2022., 2022 Abstract Background Severe atherosclerosis of the ascending aorta (SAA) in patients undergoing surgical revascularization by coronary artery bypass grafting (CABG) is becoming an increasing problem as more elderly patients are diagnosed with coronary artery disease.
Rakan I. Nazer, Ali M. Albarrati
wiley +1 more source
A remote hypertension management program clinical algorithm
Clinical Cardiology, Volume 45, Issue 12, Page 1147-1162, December 2022., 2022 Abstract Introduction Hypertension is the leading risk factor for death, affecting over one billion people worldwide, yet control rates are poor and stagnant. We developed a remote hypertension management program that leverages digitally transmitted home blood pressure (BP) measurements, algorithmic care pathways, and patient–navigator communications ...
Hunter Nichols +3 more
wiley +1 more source
The power of microRNA regulation—insights into immunity and metabolism
FEBS Letters, EarlyView.MicroRNAs are emerging as crucial regulators at the intersection of metabolism and immunity. This review examines how miRNAs coordinate glucose and lipid metabolism while simultaneously modulating T‐cell development and immune responses. Moreover, it highlights how cutting‐edge artificial intelligence applications can identify miRNA biomarkers ...
Stefania Oliveto +2 more
wiley +1 more source
Predicting progression of aortic stenosis by measuring serum calcification propensity
Clinical Cardiology, Volume 45, Issue 12, Page 1297-1302, December 2022., 2022 Abstract Background The aim of this prospective, double‐blinded study in patients with aortic sclerosis was to determine whether a new calcification propensity measure in the serum could predict disease progression. Methods We included 129 consecutive patients with aortic sclerosis as assessed during a routine clinical echocardiographic exam. Clinical,
Reto Kurmann +4 more
wiley +1 more source
The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. [PDF]
PLoS ONE, 2018 OBJECTIVES:This study aimed to examine the prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly Chinese populations. METHODS:The 2010-2012 China National Nutrition and Health Survey (CNNHS) is
Yaru Li +3 more
doaj +1 more source
Universa Medicina, 2022 BACKGROUND Dyslipidemia is of global occurrence, with a prevalence 30% or higher in several countries, including Indonesia. One risk factor of dyslipidemia is physical or mental stress, that is more frequent in women.
Sulistyowati Tuminah Darjoko +4 more
doaj +1 more source
Influence of some cardiovascular risk factors on the rela-tionship between age and blood pressure [PDF]
NORDIC BALTIC CONFERENCE ON Biomedical Engineering and Medical
Physics 2020, 2020 Blood Pressure (BP) is a biological signal related to the cardiovascular system that inevitably is affected by ageing. Moreover, it is also influenced by the presence of cardiovascular risk factors. To evaluate how the relationship be-tween BP and age changes with the presence of risk factors in hypertensive and normotensive subjects, we analyzed 880 ...
arxiv
FEBS Open Bio, EarlyView.We investigated a potential protective effect of acacetin, a naturally occurring flavonoid, against methylglyoxal (MGO)‐induced endothelial dysfunction in human umbilical vein endothelial cells and its mechanism of action. Acacetin can could inhibit MGO‐induced intracellular calcium ion influx, enhance the expression levels of phosphorylated ...
Zhen Zhang +7 more
wiley +1 more source
Clinical Cardiology, Volume 45, Issue 12, Page 1303-1310, December 2022., 2022 Abstract Background Chronic kidney disease (CKD) is a known risk factor of atherosclerotic cardiovascular disease (ASCVD). Per the 2018 American Heart Association/American College of Cardiology cholesterol guidelines, high‐risk ASCVD patients with CKD and low‐density lipoprotein cholesterol (LDL‐C) levels ≥ $\ge $ 70 mg/dL should take a high‐intensity ...
Aleesha Shaik +10 more
wiley +1 more source